Generic medications are expected to be equivalent to their brand-name counterparts — but a new study found that generic versions of certain treatments for multiple sclerosis (MS) were linked to greater variability in disease biomarkers than the original drugs. “We identified differences in circulating protein biomarker variability between brand…
Discussion
Scientists at the University of Colorado are testing an experimental approach for multiple sclerosis (MS) that uses electrical stimulation of the vagus nerve to potentially boost the brain’s ability to rewire itself and make rehabilitation more effective. The trial (NCT06641271) is enrolling by invitation at the Clinical…
Discussion
Scientists have created a “mini-brain” model, the size of a grain of rice, from human stem cells that can mimic multiple sclerosis (MS)-related damage and repair, offering a new avenue for testing drugs that restore the myelin sheath surrounding nerve fibers. The 3D spheroid model contains human nerve cells…
Discussion
Quantum Biopharma is collaborating with Thermo Fisher Scientific to prepare a Phase 2 clinical trial of Lucid-MS, an experimental oral therapy designed to slow myelin loss, in people with progressive forms of multiple sclerosis (MS). Under the agreement, Thermo Fisher’s PPD clinical research business will support…
Discussion
There’s something about the first signs of cooler weather that makes me pause and feel alive again. The days are getting shorter, the mornings feel a little different, and the air finally has a hint of crispness. After months of central Texas heat, it’s comforting to know that cooler weather…
Get regular updates to your inbox.
